| immunity, active | Resistance to a disease agent resulting from the production of specific antibodies by the host, either after exposure to the disease or after vaccination. (12 Dec 1998) |
|---|---|
| immunity, cellular | Those manifestations of the immune response which are mediated by antigen-sensitised T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. (12 Dec 1998) |
| immunity, maternally-acquired | Resistance to a disease-causing agent induced by the introduction of maternal immunity into the foetus by transplacental transfer or into the neonate through colostrum and milk. (12 Dec 1998) |
| immunity, mucosal | Nonsusceptibility to the pathogenic effects of foreign microorganisms or antigenic substances as a result of antibody secretions of the mucous membranes. Mucosal epithelia in the gastrointestinal, respiratory, and reproductive tracts produce a form of IgA (IgA, secretory) that serves to protect these ports of entry into the body. (12 Dec 1998) |
| immunity, natural | The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from non-specific mechanisms such as genetic endowment, naturally occurring antiviral and bactericidal substances, phagocytosis, and constitutional factors such as body temperature, oxygen tension, and age. (12 Dec 1998) |
| immunization | <immunology> A process that increases an organisms reaction to antigen and therefore improves its ability to resist or overcome infection. <technique> A technique used to induce immune resistance to a specific disease in humans (or other mammals) by exposing the individual to an antigen in order to raise antibodies to that antigen. (13 Oct 1997) |
| immunization program | Organised services to administer immunization procedures in the prevention of various diseases. The programs are made available over a wide range of sites: schools, hospitals, public health agencies, voluntary health agencies, etc. They are administered to an equally wide range of population groups or on various administrative levels: community, municipal, state, national, international. (12 Dec 1998) |
| immunization schedule | Schedule giving optimum times usually for primary and/or secondary immunization. (12 Dec 1998) |
| immunization, anthrax | A series of six shots over six months and booster shots annually, the anthrax vaccine now in use in the usa was first developed in the 1950s and approved by the food and drug administration for general use in 1970. It is produced by the michigan biologic products institute of michigan's department of health and is given routinely to veterinarians and others working with livestock. In december, 1997 it was announced that all us military would receive the vaccine, as do the military in the uk and russia, the reason being concern that anthrax might be used in biologic warfare. (12 Dec 1998) |
| immunization, chickenpox | This vaccine prevents the common disease known as chickenpox (varicella zoster). While chickenpox is often considered a trivial illness, it can cause significant lost time on the job and in school and have serious complications including ear infections, pneumonia, and infection of the rash with bacteria, inflammation of the brain (encephalitis) leading to difficulty with balance and coordination (cerebellar ataxia), damaged nerves (palsies), and reye's syndrome, a potentially fatal complication. The vaccination requires only one shot given at about a year of age. If an older person has not had chickenpox, the shot may be given at any time. There have been few significant reactions to the chickenpox vaccine. All children, except those with a compromised immune system, should have the vaccination. (12 Dec 1998) |
| immunization, children's | In the United States, it is recommended that all children receive vaccination against: hepatitis b diphtheria, tetanus, pertussis haemophilus influenzae type b (hib) poliovirus measles, mumps, rubella varicella zoster virus (chickenpox). Every child in the u.s. Should have these vaccinations except when there are special circumstances and the child's doctor advises specifically against a vaccination. (12 Dec 1998) |
| immunization, dpt | DPT immunization protects from diphtheria, pertussis (whooping cough), and tetanus and is given in a series of 5 shots at 2, 4, 6, 18 months of age and 4-6 years of age. Thanks to vaccination programs, these diseases have become less common. However, there are still unvaccinated individuals capable of carrying and passing diphtheria and pertussis to others who are not vaccinated. Tetanus bacteria are prevalent in natural surroundings, such as contaminated soil. See also immunization, dtap. (12 Dec 1998) |
| immunization, dt | DT (diphtheria and tetanus) vaccine does not protect from pertussis and is usually reserved for individuals who have had a significant adverse reaction to a dpt shot or who have a personal or family history of a seizure disorder or brain disease. (12 Dec 1998) |
| immunization, dtap | Like DPT, DTaP protects from diphtheria, pertussis (whooping cough) and tetanus. Dtap is the same as dtp, except that it contains only acellular pertussis vaccine which is thought to cause fewer of the minor reactions associated with immunization and is also probably less likely to cause the more severe reactions occasionally seen following pertussis vaccination. Dtap is currently recommended only for the shots given at 18 months and 4-6 years of age. (12 Dec 1998) |
| immunization, flu | The flu (influenza) vaccine is recommended for persons at high risk for serious complications from influenza infection, including everyone 65 or over; people with chronic diseases of the heart, lung or kidneys, diabetes, immunosuppression, or severe forms of anaemia; residents of nursing homes and other chronic-care facilities, children and teenagers taking aspirin therapy (and who may therefore be at risk for developing reye syndrome after an influenza infection), and those in close or frequent contact with anyone at high risk. Persons with an allergy to eggs should not receive influenza vaccine. (12 Dec 1998) |
Synonyms : Immunization Schedules, Schedule, Immunization, Schedules, Immunization
Synonyms : Passive Immunotherapy, Therapy, Immunoglobulin, Antibody Transfer, Passive, Antibody Transfers, Passive, Immunizations, Passive, Immunoglobulin Therapies, Immunotherapies, Passive, Passive Antibody Transfers, Passive Immunization, Passive Immunizations
Synonyms : Secondary Immunization, Booster Immunization, Booster Immunizations, Immunizations, Booster, Immunizations, Secondary, Secondary Immunizations
Synonyms : Immunoassays
Synonyms : Angioimmunoblastic Lymphadenopathies, Immunoblastic Lymphadenopathies, Lymphadenopathies, Angioimmunoblastic, Lymphadenopathies, Immunoblastic, Lymphadenopathy, Angioimmunoblastic
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|---|---|---|---|
|
이뮤넥스산 - 새창
|
씨트리 |
Echinacea extract | 일반의약품 | 비급여 |
|
|
이뮤넥스정 - 새창
|
씨트리 |
Echinacea extract | 일반의약품 | 비급여 |
|
|
펜타글로빈주사액50ml - 새창
|
Biotest Pharma |
E03150211 | Immunoglobulin-M, enriched human | 전문의약품 | 급여 | 분업예외의약품 |
|
메갈로텍주50ml - 새창
|
Biotest Pharma |
E03150123 | Immunoglobulin G, human cytomegalovirus | 전문의약품 | 급여 | 분업예외의약품 |
|
메갈로텍주20ml - 새창
|
Biotest Pharma |
E03150122 | Immunoglobulin G, human cytomegalovirus | 전문의약품 | 급여 | 분업예외의약품 |
|
이뮤노액 - 새창
|
코오롱제약 |
Echinacea extract | 일반의약품 | 미생산 |
|
|
이뮤넥스액 - 새창
|
씨트리 |
Echinacea extract | 일반의약품 | 비급여 |
|
|
오에스카드 - 새창
|
삼천당제약 |
A08402721 | Immunoglobulin, Monoclonal anti β-HCG antibody, Polyclonal Antibody | 전문의약품 | 삭제 | 분업예외의약품 |
|
이뮤코텔주1mg - 새창
|
biosyn |
Immunocyanin | 일반의약품 | 비급여 |
|
|
이뮤코텔주10mg - 새창
|
biosyn |
Immunocyanin | 전문의약품 | 비급여 |
| immunoassay |
identification of a substance (especially a protein) by its action as an antigen; "PSA in the blood can be measured with an immunochemical assay"
출처: wordnet.princeton.edu/perl/webwn
|
|---|---|
| immunochemistry |
the field of chemistry concerned with chemical processes in immunology (such as chemical studies of antigens and antibodies)
출처: wordnet.princeton.edu/perl/webwn
|
| immunocompetence |
the ability to develop an immune response following exposure to an antigen
출처: wordnet.princeton.edu/perl/webwn
|
| immunocompromised |
unable to develop a normal immune response usually because of malnutrition or immunodeficiency or immunosuppressive therapy
출처: wordnet.princeton.edu/perl/webwn
|
| immune serum globulin |
immunoglobulin: a class of proteins produced in lymph tissue in vertebrates and that function as antibodies in the immune response
출처: wordnet.princeton.edu/perl/webwn
|
| immun | one of the five major classes of immunoglobulins |
|---|---|
| immun | one of the five major classes of immunoglobulins |
| immun | one of the five major classes of immunoglobulins |
| immun | one of the five major classes of immunoglobulins |
| immun | of or relating to immunology |
| immun | a bodily defense reaction that recognizes an invading substance (an antigen: such as a virus or fungus or bacteria or transplanted organ) and produces antibodies specific against that antigen |
| immun | of or relating to immunology |
| immun | a disorder of the immune system |
| immun | a medical scientist who specializes in immunology |
| immun | the branch of medical science that studies the body's immune system |
| immun | the branch of immunology that deals with pathologies of the immune system |
| immun | a drug that lowers the body's normal immune response |